Alzheimer's disease risk variants show association with cerebrospinal fluid amyloid beta

Neurogenetics

Volumn 10, Issue 1, 2009, Pages 13-17

  Kauwe, John S K ^a   Wang, Jun ^a   Mayo, Kevin ^a   Morris, John C ^a   Fagan, Anne M ^a   Holtzman, David M ^a   Goate, Alison M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Amyloid beta; Association; Genetics; Transferrin

Indexed keywords

AMYLOID BETA PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; DATABASES, GENETIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 58649091124     PISSN: 13646745     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10048-008-0150-4     Document Type: Article

References (23)

1. JL Price JC Morris 1999 Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease Ann Neurol 45 358 368
2. JC Morris M Storandt JP Miller DW McKeel JL Price EH Rubin 2001 Mild cognitive impairment represents early-stage Alzheimer disease Arch Neurol 58 397 405
3. CM Hulette KA Welsh-Bohmer MG Murray AM Saunders DC Mash LM McIntyre 1998 Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals J Neuropathol Exp Neurol 57 1168 1174
4. DA Bennett JA Schneider Z Arvanitakis JF Kelly NT Aggarwal RC Shah 2006 Neuropathology of older persons without cognitive impairment from two community-based studies Neurology 66 1837 1844
5. JS Kauwe S Jacquart S Chakraverty J Wang K Mayo AM Fagan 2007 Extreme cerebrospinal fluid amyloid beta levels identify family with late-onset Alzheimer's disease presenilin 1 mutation Ann Neurol 61 446 453
6. AM Fagan MA Mintun RH Mach SY Lee CS Dence AR Shah 2006 Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans Ann Neurol 59 512 519
7. AM Fagan CM Roe C Xiong MA Mintun JC Morris DM Holtzman 2007 Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults Arch Neurol 64 343 349
8. L Bertram MB McQueen K Mullin D Blacker RE Tanzi 2007 Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database Nat Genet 39 17 23
9. C Ding CR Cantor 2003 A high-throughput gene expression analysis technique using competitive PCR and matrix-assisted laser desorption ionization time-of-flight MS Proc Natl Acad Sci U S A 100 3059 3064
10. DM Holtzman AM Fagan B Mackey T Tenkova L Sartorius SM Paul 2000 Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model Ann Neurol 47 739 747
11. J Kim L Onstead S Randle R Price L Smithson C Zwizinski 2007 Abeta40 inhibits amyloid deposition in vivo J Neurosci 27 627 633
12. D Scheuner C Eckman M Jensen X Song M Citron N Suzuki 1996 Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease Nat Med 2 864 870
13. F Dudbridge 2003 Pedigree disequilibrium tests for multilocus haplotypes Genet Epidemiol 25 115 121
14. J Wang D Beher AC Nyborg MS Shearman TE Golde A Goate 2006 C-terminal PAL motif of presenilin and presenilin homologues required for normal active site conformation J Neurochem 96 218 227
15. B Keavney CA McKenzie JM Connell C Julier PJ Ratcliffe E Sobel 1998 Measured haplotype analysis of the angiotensin-I converting enzyme gene Hum Mol Genet 7 1745 1751
16. PG Kehoe H Katzov L Feuk AM Bennet B Johansson B Wiman 2003 Haplotypes extending across ACE are associated with Alzheimer's disease Hum Mol Genet 12 859 867
17. JA Prince H Zetterberg N Andreasen J Marcusson K Blennow 2004 APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42 Neurology 62 2116 2118
18. O Belbin JL Dunn Y Ling L Morgan S Chappell H Beaumont 2007 Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene and the rate of cognitive decline in Alzheimer's disease Hum Mol Genet 16 2199 2208
19. J Hu A Igarashi M Kamata H Nakagawa 2001 Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity J Biol Chem 276 47863 47868
20. Y Li A Grupe C Rowland P Nowotny JS Kauwe S Smemo 2006 DAPK1 variants are associated with Alzheimer's disease and allele-specific expression Hum Mol Genet 15 2560 2568
21. LJ Morse SM Payton GD Cuny JT Rogers 2004 FDA-preapproved drugs targeted to the translational regulation and processing of the amyloid precursor protein J Mol Neurosci 24 129 136
22. L Reznichenko T Amit H Zheng Y Avramovich-Tirosh MB Youdim O Weinreb 2006 Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease J Neurochem 97 527 536
23. Schjeide B-MM, McQueen MB, Mullin K, DiVito J, Hogan MF, Parkinson M, Hooli B, Lange C, Blacker D, Tanzi RE, Bertram L (2009) Assessment of Alzheimer's disease case-control associations using family-based methods. Neurogenetics. doi: 10.1007/s10048-008-0151-3